iCo Therapeutics Oral Amphotericin B Poster at AAPS
November 18, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to report
November 18, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to report
For Immediate Release November 17, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) today
November 7, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to report
October 9, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce
October 1, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO), a reprofiling company focused
September 29, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO), a reprofiling company focused
September 22, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to report
September 4, 2008 VANCOUVER, Canada—iCo Therapeutics Inc. (TSX-V: ICO) is pleased to provide an
August 28, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) today reported interim financial
July 8, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce